Our Leadership

The Institute is governed by an executive board of directors, supported by a multidisciplinary Advisory Board and an Expert Network of industry and academic professionals.

Selected from Catalent’s world-class array of strategic and scientific talent, the Institute leadership team brings a broad range of experience and a passion for learning and collaboration to this new initiative.

Board of Advisors

  • ADVISORY BOARD MEMBER, CATALENT APPLIED DRUG DELIVERY INSTITUTE CHAIR, NON-INVASIVE MACROMOLECULE DELIVERY CONSORTIUM

    Professor of Pharmacy and Pharmacology at University of Bath and Chief Science Officer & Co-founder of Applied Molecular Transport

  • ADVISORY BOARD MEMBER, CATALENT APPLIED DRUG DELIVERY INSTITUTE

    Drug delivery innovator and established academic professor at The University of Saarland and Head of the Infectious Disease Department at the Helmholtz Institute.

  • ADVISORY BOARD MEMBER, CATALENT APPLIED DRUG DELIVERY INSTITUTE

    Industry veteran with over 35 years of experience, mostly recently as the Head of Pfizer’s Global PTx Pharmaceutical Sciences group

Board of Directors

  • Vice President, Corporate Development & Strategy

    More than 20 years of experience in the pharmaceutical industry.

  • Global Vice President, Marketing & Strategy

    Extensive healthcare industry experience at Johnson & Johnson and Ernst &Young

  • Vice President, Science and Technology

    Extensive experience in bioavailability and oral drug development.

Drug Delivery Expert Network

The Institute also leverages contributions from a wide multidisciplinary network of distinguished experts in Drug Development and Delivery across industry and academia, some of which are listed here.

In addition, the Institute leverages contributions from nearly 100 Catalent experts in drug development and delivery. Widely known in the industry as subject matter experts, these individuals have contributed significantly as internal speakers at our webinar series; presented posters, papers and workshops for the American Association of Pharmaceutical Scientists (AAPS) and other leading organizations; published case studies, white paper and research articles; hold numerous patents; and contribute significantly to Catalent’s intellectual property and drug delivery, development and commercialization efforts over the last 80 years.